Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dca045c36d62e95b49a60f971a1a2dc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
filingDate |
2007-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b5095bf24df8c62f782614b0fda6c0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04d8a6d416ee17310d54d8d96972c7b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bc522918452ae9dbe4bc58d88eebceb |
publicationDate |
2008-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008187528-A1 |
titleOfInvention |
Anti-tsg101 antibodies and their uses for treatment of viral infections |
abstract |
The present invention provides antibodies that bind to the C-terminal region of TSG101. The invention also provides methods of using the TSG101 antibodies for the treatment of viral infections, including HIV and Ebola virus infection. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7981410-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008124341-A1 |
priorityDate |
2006-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |